2021 House Bill 5570 ↩

Senate Roll Call 82: The amendment was not adopted

To tie-bar the bill to Senate Bill 961, meaning this bill cannot become law unless that one does also. SB 961 would rescind provisions of a 1995 law that limited damage awards sought by plaintiffs and trial attorneys against drug companies for selling drugs approved by the U.S. Food and Drug Administration.